Eu Ivdd Eu Ivd General On The Market 🇨🇳 China

MULTIPLE VIRUSES - MULTIPLEX ASSAYS - OTHER

Devices (same UDI-DI)
1
Certificates
0
Countries
13
Notified Bodies
0

Let the assistant research this device

The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.

Free to try · every answer cites its records

Basic Information

Primary DI
D-000041242SI003-013W
Basic UDI-DI Code
B-000041242SI003-013W
Reference
SI003-01
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market

Additional Description

The COVID-19 and Influenza A+B Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A and Influenza B virus antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/Influenza infection in conjunction with clinical presentation and the results of other laboratory tests.

CND Nomenclature Codes

Code Description
W0105070399 MULTIPLE VIRUSES - MULTIPLEX ASSAYS - OTHER

Available In Countries

🇧🇬 Bulgaria 🇨🇾 Cyprus 🇩🇪 Germany 🇪🇪 Estonia 🇭🇷 Croatia 🇱🇮 Liechtenstein 🇱🇹 Lithuania 🇱🇺 Luxembourg 🇱🇻 Latvia 🇲🇹 Malta 🇷🇴 Romania 🇸🇮 Slovenia 🇸🇰 Slovakia

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all